Clinical trial

Docetaxel in Node Positive Adjuvant Breast Cancer

NCT00688740

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1997-06-01

PhasePHASE3

Study timeline

Study start (unknown)1997-06-01Date precision: month

Registry last updated2011-02-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

DocetaxelDRUG · verified · RxNorm: docetaxel

5-fluorouracilDRUG

DoxorubicinDRUG · verified · RxNorm: doxorubicin

CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide

Sponsors & collaborators

Sanofilead sponsor

Cancer International Research Group (CIRG)collaborator

Mapped research locations

BarcelonaSpain1 ParisFrance1 BerlinGermany1 WarsawPoland1 BudapestHungary1 PragueCzechia1 ViennaAustria1 Buenos AiresArgentina1 São PauloBrazil1 AthensGreece1 BratislavaSlovakia1 CairoEgypt1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00688740 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.